Related Experiment Video
Updated: Mar 11, 2026

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
12.6K
Clinical features of diffuse large B-cell lymphoma with polyploidy
Joji Shimono1,2, Hiroaki Miyoshi1, Masao Seto1
1Department of Pathology, Kurume University, School of Medicine, Kurume, Japan.
Pathology International
|November 22, 2016
Summary
Polyploidy, an increase in chromosome sets, is identified in diffuse large B-cell lymphoma (DLBCL). This finding reveals a distinct DLBCL subtype with unique features, potentially guiding personalized treatment strategies.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Polyploidy, the presence of more than two sets of homologous chromosomes, is implicated in various malignant tumors.
- Its role in diffuse large B-cell lymphoma (DLBCL) pathogenesis remained unexplored.
- This study investigates polyploidy in DLBCL for the first time.
Purpose of the Study:
- To investigate the clinicopathological features of polyploid diffuse large B-cell lymphoma (DLBCL).
- To determine the frequency and characteristics of polyploidy in DLBCL cases.
- To assess the clinical implications and potential therapeutic responses in polyploid DLBCL.
Main Methods:
- Review of 16 DLBCL cases with polyploidy, defined by G-band analysis showing near-tetraploid or greater chromosome numbers.
- Analysis of clinicopathological features including cell morphology, immunophenotype (CD5, CD30, EBER, Bcl2), and infiltration patterns.
- Evaluation of treatment response and survival in polyploid DLBCL patients.
Main Results:
- Polyploid DLBCL occurred in 2.9% of cases (16/544), predominantly near-tetraploid.
- Polyploid DLBCL showed increased numbers of huge and multinucleated cells compared to non-polyploid DLBCL.
- Cases exhibited reduced extranodal infiltration and major lymph node involvement; 6 of 7 treated patients responded to chemotherapy.
Conclusions:
- Polyploid DLBCL represents a distinct clinicopathological subtype.
- Understanding these features aids in personalized management strategies for DLBCL patients.
- This research highlights the significance of chromosomal abnormalities in DLBCL.
Related Concept Videos
Polytene Chromosomes
11.2K
Polytene chromosomes are giant interphase chromosomes with several DNA strands placed side by side. They were discovered in the year 1881 by Balbiani in salivary glands, intestine, muscles, malpighian tubules, and hypoderm of larvae Chironomus plumosus. Hence, these are also called "Salivary gland chromosomes." These are found in insects of the order Diptera and Collembola; in certain organs of mammals; and synergids, antipodes of flowering plants. Polytene chromosomes are also...
11.2K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Disorders of Leukocytes
2.3K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
Cells of the Adaptive Immune Response
9.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.8K
Primary Lymphoid Organs
16.4K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.4K
B Cell Activation and Differentiation
17.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.7K

